State Street’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.6M | Sell |
|
|||||
|
2025
Q2 | $18.5M | Buy |
|
|||||
|
2025
Q1 | $13.3M | Buy |
|
|||||
|
2024
Q4 | $19M | Buy |
|
|||||
|
2024
Q3 | $64.7M | Sell |
|
|||||
|
2024
Q2 | $55.8M | Sell |
|
|||||
|
2024
Q1 | $103M | Buy |
|
|||||
|
2023
Q4 | $41.9M | Buy |
|
|||||
|
2023
Q3 | $28.8M | Sell |
|
|||||
|
2023
Q2 | $40.8M | Buy |
|
|||||
|
2023
Q1 | $40.3M | Sell |
|
|||||
|
2022
Q4 | $46.5M | Buy |
|
|||||
|
2022
Q3 | $35.1M | Sell |
|
|||||
|
2022
Q2 | $27.4M | Buy |
|
|||||
|
2022
Q1 | $37.2M | Buy |
|
|||||
|
2021
Q4 | $38.3M | Sell |
|
|||||
|
2021
Q3 | $26.8M | Sell |
|
|||||
|
2021
Q2 | $28.8M | Sell |
|
|||||
|
2021
Q1 | $44.6M | Buy |
|
|||||
|
2020
Q4 | $30.1M | Buy |
|
|||||
|
2020
Q3 | $3.83M | Buy |
|
|||||
|
2020
Q2 | $3.19M | Buy |
|